News/ News/ R&D Cerevel soars on first data for muscarinic schizophrenia drug Phil Taylor central nervous system, Cerevel Therapeutics, psychosis, schizophrenia 0 Comment Shares in Pfizer spinout Cerevel Therapeutics have more than doubled after it reported positive early-stage results with CVL-231, Share X Cerevel soars on first data for muscarinic schizophrenia drug https://pharmaphorum.com/news/cerevel-soars-on-first-data-for-muscarinic-schizophrenia-drug/